Growing Antibody Industry in China Sees Major Opportunities
Yet, Challenges Remain as Companies Need More Talent and Resources to Market Globally
The Top 10 Highest-Paid Women Executives in Biopharma
Compensation Has Climbed since 2014, yet Gap with Male Counterparts Remains
BioTrinity Conference Focuses on NextGen Healthcare
Meeting Highlights Array of Technologies and Promising Methodologies
Supplement: CRISPR Shakes Up Tools and Tech
Innovators Are Developing More Precise DNA-Cutting and Single-Cell-Seeding Platforms
For full access to this article login to GEN Select now.
RNAi Therapeutics: To the Liver ... and Beyond
RNAi Therapy Components Are Surviving Degradation, Staying Potent, and Reaching More Targets Than Ever
- As a means of perturbing gene expression—and avoiding manipulation of the genome—RNA interference (RNAi) has distinct advantages. RNAi, it must be said, is hardly unique in its ability to target individual genes. This ability is shared by RNAi with CRISPR inteference (CRISPRi), which may provide even better gene targeting ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.